WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Stereo Investigator
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harden, D. G.
Right arrow Articles by Grace, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harden, D. G.
Right arrow Articles by Grace, A. A.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 15, 6157-6166, Copyright © 1995 by Society for Neuroscience


ARTICLE

Activation of dopamine cell firing by repeated L-DOPA administration to dopamine-depleted rats: its potential role in mediating the therapeutic response to L-DOPA treatment

DG Harden and AA Grace
Department of Neuroscience, University of Pittsburgh, Pennsylvania 15260, USA.

The administration of L-dihydroxyphenylalanine (L-DOPA) to patients with Parkinson's disease is known to produce acute effects that include the reduction of rigidity as well as delayed therapeutic actions involving the resumption of complex motor behavior. In order to examine the potential role of dopamine (DA) cell activity in mediating these responses, the effects of acute and repeated L-DOPA administration on the electrophysiological activity of the residual dopamine (DA) neurons were examined in rats that had received partial 6-hydroxydopamine (6- OHDA)-induced DA lesions. DA cell activity was assessed along three dimensions: (1) the relative proportion of DA neurons exhibiting spontaneous spike firing, (2) their basal firing rate, and (3) their firing pattern. Following 6-OHDA-induced DA depletion, rats were treated for 1 month with saline or L-DOPA. In addition, rats from each group received either an acute injection of L-DOPA or saline on the day of recording. In rats receiving repeated saline treatment, the DA neurons recorded following acute L-DOPA administration were firing at significantly slower basal firing rates and exhibited less burst firing when compared to saline-pretreated rats given acute saline. In contrast, DA cells recorded from rats that had received repeated L-DOPA administration for 4 weeks followed by an acute saline injection did not exhibit any significant differences from DA cells of intact control rats with respect to basal firing rate or firing pattern; however, there was a substantial increase in the proportion of DA neurons exhibiting spontaneous spike firing after correcting for 6-OHDA-induced cell loss. In addition, in rats receiving repeated L-DOPA treatment, the DA cells recorded following acute administration of L-DOPA showed significantly less of a reduction in firing rate when compared to the cells recorded following acute L-DOPA in the saline treatment group. These results show that: (1) acute L-DOPA administration appears to exert its actions by DA autoreceptor stimulation, whereas (2) repeated L-DOPA administration increases the proportion of spontaneously active DA neurons in partially lesioned rats. As a result, repeated L-DOPA administration would be expected to cause an increase in spike- dependent DA release as a consequence of the greater proportion of DA cells showing spontaneous activity. This may be the major factor underlying the delayed therapeutic benefits of L-DOPA therapy in the treatment of Parkinson's disease.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Robinson, D. M. Smith, S. J. Y. Mizumori, and R. D. Palmiter
From The Cover: Firing properties of dopamine neurons in freely moving dopamine-deficient mice: Effects of dopamine receptor activation and anesthesia
PNAS, September 7, 2004; 101(36): 13329 - 13334.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. O. Komendantov and C. C. Canavier
Electrical Coupling Between Model Midbrain Dopamine Neurons: Effects on Firing Pattern and Synchrony
J Neurophysiol, March 1, 2002; 87(3): 1526 - 1541.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
R. Cools, R. A. Barker, B. J. Sahakian, and T. W. Robbins
Enhanced or Impaired Cognitive Function in Parkinson's Disease as a Function of Dopaminergic Medication and Task Demands
Cereb Cortex, December 1, 2001; 11(12): 1136 - 1143.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. R. West and A. A. Grace
Striatal Nitric Oxide Signaling Regulates the Neuronal Activity of Midbrain Dopamine Neurons In Vivo
J Neurophysiol, April 1, 2000; 83(4): 1796 - 1808.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Ekesbo, E. Rydin, R. Torstenson, O. Sydow, B. Laengstrom, and J. Tedroff
Dopamine autoreceptor function is lost in advanced Parkinson's disease
Neurology, January 1, 1999; 52(1): 120 - 120.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. A. Mena, V. Davila, J. Bogaluvsky, and D. Sulzer
A Synergistic Neurotrophic Response to l-Dihydroxyphenylalanine and Nerve Growth Factor
Mol. Pharmacol., October 1, 1998; 54(4): 678 - 686.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Bordet, S. Ridray, S. Carboni, J. Diaz, P. Sokoloff, and J.-C. Schwartz
Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa
PNAS, April 1, 1997; 94(7): 3363 - 3367.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-